---
id: RA-001
title: "Building Trust Across the Pharmaceutical Supply Chain"
subtitle: "A Reference Architecture for End-to-End Traceability"
author: "A. S. Tomar"
author_role: "KryoNex Research & Engineering Team"
status: working-draft
document_version: 0.4
publish_date: ""
last_updated: "2026-07-24"
tags:
  - pharmaceutical-traceability
  - supply-chain
  - GS1-EPCIS
  - serialization
  - IoT
  - digital-trust
---
# RA-001 Changelog

All notable research, architecture, evidence, and publication-state changes to
RA-001 are recorded here.

RA-001 follows research-document versioning. A working-draft version does not
indicate production validation or regulatory approval.

---

## [0.4] — 2026-07-24

### Research

- Established the current-state analysis of pharmaceutical product
  identification, serialization, aggregation, traceability-event exchange,
  enterprise systems, regulatory ecosystems, and environmental observations.
- Separated U.S. DSCSA, European medicines-verification, and Indian
  domestic/export contexts rather than treating them as one global
  traceability model.
- Established claim-level evidence tracking through
  `sources/evidence-register.md`.
- Distinguished standards capability, regulatory requirements, industry
  implementation patterns, peer-reviewed research, and KryoNex Research
  architectural synthesis.

### Architecture

- Established F01 — Contemporary Pharmaceutical Supply Chain as the physical
  reference model.
- Developed F02 — Current Pharmaceutical Traceability Landscape as the
  current-state digital and organizational systems model.
- Developed F03 — Trust & Visibility Boundaries as the conceptual assurance
  model.
- Established the principle that an assurance boundary does not itself
  constitute a control failure.
- Defined four assurance dimensions for subsequent architectural analysis:
  product identity, event integrity, organizational authority, and observation
  correlation.
- Preserved authoritative regulatory and enterprise systems rather than
  assuming replacement by a new platform.
- Maintained blockchain and distributed-ledger mechanisms as optional
  architectural candidates rather than foundational requirements.

### Figures

- Added F01 physical supply-chain reference figure.
- Added F02 current traceability landscape figure.
- Added F03 trust and visibility boundaries figure.
- Retained figure-version review as part of the final publication freeze.

### Editorial

- Adopted vendor-neutral and research-oriented terminology.
- Separated physical-world evidence from digital assertions.
- Removed unsupported universal performance and adoption claims.
- Added explicit limitations and production-validation boundaries.
- Established architectural provenance for KryoNex Research synthesis.

### Publication Status

RA-001 remains **Version 0.4 — Working Draft / Under Technical Review**.

F04 — Proposed Logical Reference Architecture remains under development.

No v1.0 publication claim is made by this release.
